Abstract:Senolytic drugs (Anti-aging drugs) selectively eliminate senescent cells (SC), which are resistant to apoptosis and have up-regulated anti-apoptotic pathways that protect them from their inflammatory senescence-associated secretory phenotype (SASP). These drugs temporarily disable these pathways, inducing apoptosis in SCs with a tissue-destructive SASP. Initially identified through hypothesis-driven research, senolytics like Dasatinib, Quercetin, Fisetin, and Navitoclax have shown in preclinical models to delay, prevent, or alleviate frailty, cancers, and various disorders as well as complications from organ transplantation. Senolytics like Azithromycin and Quercetin, which have anti-aging properties, are proposed as potential treatments. Since 2015, several senolytics have progressed to clinical trials. Recent studies link chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) to accelerated aging mechanisms, including cellular senescence. COPD's diversity, with its range of phenotypes, implies that lung aging may play varying roles in different phenotypes, complicating the identification of COPD patients who might benefit from senolytics. Preclinical evidence suggests senolytics reduce all-cause mortality, enhance physical function and resilience, and alleviate diseases across various organs, even in elderly patients. Diet provides energy, nutrition, and enjoyment. Studies show that major dietary components regulate aging and longevity. The potential for other dietary ingredients to prevent aging and extend longevity is intriguing. Recent findings suggest that certain plant-based ingredients can extend longevity by regulating metabolism, targeting TRP channels, reactive oxygen species (ROS), promoting mitophagy, influencing senescence pathways, and modulating circadian rhythms. Understanding these may help develop interventions for aging and related diseases. Calorie restriction and dietary manipulations that reduce ROS and inflammation while promoting autophagy can extend lifespan in model organisms. Some phytochemicals also extend lifespan in animals. This review examines the role of senescent cells in aging and disease, methods for discovering and refining senotherapeutics, and the status of senolytic preclinical and clinical trials and highlights anti-aging phytochemicals studied in cells, animals, and humans, exploring their cellular and molecular mechanisms.

Enalapril mitigates aging by targeting antioxidative genes via phosphorylated Smad1/5/9

Rosuvastatin-attenuated heart failure in aged spontaneously hypertensive rats via PKCα/β2 signal pathway.

Renin-angiotensin system inhibitors positively impact on multiple aging regulatory pathways: Could they be used to protect against human aging?

Anemonin Ameliorates Human Diploid Fibroblasts 2BS and IMR90 Cell Senescence by PARP1-NAD+-SIRT1 Signaling Pathway.

Chronic angiotensin converting enzyme inhibition attenuates frailty and protects against atrial fibrillation in aging mice

Repurposing the plant-derived compound apigenin for senomorphic effect in antiaging pipelines

Targeting Autophagy in Aging and Aging-Related Cardiovascular Diseases

Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat

The Anti-Aging Effect of Erythropoietin Via the ERK/Nrf2-ARE Pathway in Aging Rats

Selective Phosphodiesterase 1 Inhibition Ameliorates Vascular Function, Reduces Inflammatory Response, and Lowers Blood Pressure in Aging Animals

AMPK Activator O304 Protects Against Kidney Aging Through Promoting Energy Metabolism and Autophagy

Apelin/APJ system: A novel promising target for anti-aging intervention

Astragalus polysaccharides attenuate rat aortic endothelial senescence via regulation of the SIRT-1/p53 signaling pathway

Angiotensin converting enzyme inhibitor up regulates the expression of estrogen receptors in the kidney in old female rats.

The pro-resolving mediator, annexin A1 regulates blood pressure, and age-associated changes in cardiovascular function and remodeling

Bioactive Peptides From Angelica Sinensis Protein Hydrolyzate Delay Senescence In Caenorhabditis Elegans Through Antioxidant Activities

Targeting AMPK Signaling by Polyphenols: a Novel Strategy for Tackling Aging

Effect of telmisartan on nitric oxide--asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial aging

Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury

Chronological attenuation of NPRA/PKG/AMPK signaling promotes vascular aging and elevates blood pressure

Senolytics and Dietary Phytochemicals: Exploring Anti-Aging Strategies and Mechanisms in Aging and Disease